SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following its recent licensing deal and talent acquisition from AI chip startup Groq, a move widely seen to bolster its AI inference capabilities. The community is sharply divided, with bulls viewing it as a strategic expansion cementing NVIDIA's leadership, while bears critique it as an overpriced, desperate maneuver amidst a shifting AI hardware landscape and intensifying competition. This deal fuels intense debate over the company's long-term dominance beyond AI training.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is experiencing intense bullish momentum, driven by spot silver prices reaching new record highs in Shanghai and upcoming Chinese export restrictions. This surge is further fueled by critical industrial demand from AI data centers and green energy, prompting community discussion of a potential "silver squeeze" and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is experiencing a significant surge following FDA approval of YARTEMLEA, marking it as the first and only approved therapy for transplant-associated thrombotic microangiopathy. Community sentiment is overwhelmingly bullish, anticipating a substantial short squeeze and massive revaluation, citing the drug's potential in a high-need market with no competition. Investors are also factoring in the company's strengthened financial position, including a multi-billion dollar partnership with Novo Nordisk, as key drivers for future growth.

Boundless is a universal protocol that brings ZK to every chain. Using Boundless, developers can create expressive, high-throughput applications that bypass traditional block size/gas limits.  Developers submit proof requests and provers compete to fulfill them, earning direct rewards and protocol-level incentives through proof of verifiable work.  By abstracting away the complexity of proof generation, aggregation, and onchain settlement, Boundless allows developers to build without worrying about underlying infrastructure, while provers provide strong liveness guarantees, censorship-resistance, and continuously improve the cost curve driven by open market dynamics.  This architecture decouples execution from consensus and introduces a new paradigm for verifiable computing. As the number of Boundless prover nodes grows, the total capacity of the protocol increases, scaling compute across every chain.

Boundless

ZKC is trending with the launch of its new data availability layer, positioning itself as a crucial Ethereum scaling solution and competitor to Celestia. Community discussion emphasizes strong expectations for a significant reversal and substantial upside, with many viewing it as a prime opportunity after recent price action.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is generating significant buzz following multiple analyst upgrades and heightened anticipation for potential partnership announcements, especially at the upcoming CES event. The community is actively debating the stock's trajectory, with many accumulating shares based on conviction in its agentic voice AI technology and substantial contract backlog, while others express frustration over recent underperformance and insider selling.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

SQD is experiencing heightened community interest and buying pressure, primarily driven by its acquisition by Rezolve AI and the anticipated release of Tokenomics 2.0. Traders are actively discussing its foundational utility as a decentralized blockchain data platform supporting numerous blockchains, eyeing its potential for a substantial rally.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

The aerospace sector is buzzing with speculation around a potential SpaceX IPO, driving significant investor attention to related companies. The community is actively discussing firms like MNTS, highlighted for its partnership with SpaceX on upcoming Falcon 9 missions and its extremely low share count. This interest is amplified by MNTS's involvement in projects like 'Golden Dome,' positioning it as a key indirect play on the anticipated SpaceX market debut.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health is a prominent topic amid broader political discussions surrounding Affordable Care Act subsidies, which are critically impacting the outlook for managed care organizations. Community sentiment reveals a mix of bullish options activity anticipating future gains and cautious perspectives regarding persistent medical cost trends and potential shifts in healthcare policy. This creates a dynamic environment where investors are weighing ELV's perceived undervaluation against sector-wide uncertainties, despite some recent analyst upgrades.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoin is a major talking point with widespread options activity and varied community sentiment as institutional engagement continues to grow, evidenced by major financial platforms embracing crypto ETFs. This interest fuels debates about its resilience and potential for significant price movements, juxtaposed with concerns over market volatility and broader economic influences.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is a key focus for investors with the January 31, 2026 PDUFA date nearing for Anaphylm, its needle-free epinephrine sublingual film. Community discussion highlights strong optimism for approval, driven by positive clinical data, the FDA's AdCom waiver, and the product's unique convenience for a critical unmet medical need. However, dialogue also reflects significant attention to market pressures, including rising short interest and competitor-driven concerns that could influence the regulatory timeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Radiant Logistics, Inc. is a third-party logistics company, providing technology-enabled global transportation and value-added logistics services. It operates through the U.S. and Canada geographical segments. The company was founded by Bohn H. Crain on March 15, 2001 and is headquartered in Renton, WA.

Current Price	$6.49
Prev Close	$6.52
Open	$6.50
Dividend Yield	0.00%
50-Day Moving Average	$6.23
Beta	1.02
Avg. Volume	178,136.84
PE Ratio	20.83

52-Week High	$7.94
52-Week Low	$5.44
Market Capitalization	$311.41M
EPS (Annual)	$0.3548
Price to Book	1.36
Revenue Per Employee	$879,820.66
Enterprise Value/EBITDA	N/A

RLGT
Radiant Logistics, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RLGT News

RLGTRadiant Logistics, Inc.